NR 508 (NR 508)

NR 508 | NR508 Advanced Pathophysiology- Endocrine Study guide.

NR 508 - Week 7 Exam /NR 508 - Week 7 Exam. Digoxin levels need to be monitored closely when the following medication is started: 4. Albuterol Patients with pheochromocytoma should avoid which of the following classes of drugs because of the possibility of developing hypertensive crisis? 2. Beta-2-agonists Harold, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all? 2. Salmeterol, an inhaled long-act...

NR 508 - Week 5 Exam/NR 508 - Week 5 Exam. Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: Bisphosphonates treat or prevent osteoporosis by:

NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3)/NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3). A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should:

NR 508 - Mental Health Exam 2 Review/NR 508 - Mental Health Exam 2 Review.

NR 508 - Week 5 Exam 2020/NR 508 - Week 5 Exam 2020.

NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3)/NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3).

NR 508 - Week 7 Exam 2020/NR 508 - Week 7 Exam 2020.

NR 508 - Week 3 Exam Study Guide (100% correct)/NR 508 - Week 3 Exam Study Guide (100% correct).

NR 508 ADVANCED PHARM MIDTERM EXAM EXAM 3 A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medication to cholestyramine (Questran). Correct!...